Poland· PL-100463263

Citogla

A citicoline product containing citicolinum, registered in Poland by RA Progress Maciej Mirakowski. The same ATC class is registered in 3 of our 19 countries.

ATC N06BX06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCitoglaATCN06BX06REGISTER NO.PL-100463263PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Citicoline is registered in 3 of 19 countries.

Countries holding a registration under ATC N06BX06 (citicoline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Citicoline · ATC N06BX06

3 / 19 countries

  • Japan
  • Polandprice
  • Spainprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Citicolinum
Manufacturer
RA Progress Maciej Mirakowski
Country
Poland (PL)
ATC code
N06BX06
ATC class
Citicoline
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05907572581485
  • gtin
    05907572581492
  • gtin
    05907572581508

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Citicoline in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All citicoline products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Startonyl
  • Bulgaria · Ситико, Сомазина
  • Spain · Cikappa, Citicolina Cinfamed
  • Italy · Breinural, Cidilin
  • Malta · Somazina
  • Portugal · Citicolina Viatris, Citicolina Vitória

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/177efdbc-ff50-42c0-a74e-6ac1e5fa9279
GET /v1/drugs/177efdbc-ff50-42c0-a74e-6ac1e5fa9279?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05907572581485 ¦ Rp ¦ 165774\n10 tabl.\n05907572581492 ¦ Rp ¦ 165775\n20 tabl.\n05907572581508 ¦ Rp ¦ 165776\n30 tabl.",
  "substance": "Citicolinum natricum 522.5 mg",
  "common_name": "Citicolinum",
  "pl_product_id": "100463263",
  "pozwolenie_nr": "29808",
  "auth_procedure": "NAR",
  "authorisation_validity": "2031-07-07"
}

See everything about citicoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.